Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K053567
    Manufacturer
    Date Cleared
    2006-03-06

    (74 days)

    Product Code
    Regulation Number
    888.1100
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K011083, K052686

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ArthroCare Topaz ArthroWands are indicated for debridement, resection, ablation, The Arthroom's ropas Firms and hemostasis of blood vessels in arthroscopic and orthopedic procedures:

    Procedures: Fasciotomy, Synovectomy, Tendonotomy, Rotator Cuff Tendonotomy, Capsulotomy

    Body Structure as described below: Foot, Knee, Wrist, Elbow, Ankle, Shoulder

    Device Description

    The ArthroCare Topaz ArthroWands are bipolar, single use, high frequency electrosurgical devices designed for specific indications in arthroscopic and orthopedic procedures.

    AI/ML Overview

    This submission K053567 is for a new indication and labeling for an existing device. As such, it does not include data for performance acceptance criteria or a study to demonstrate that it meets the criteria.

    Here's a breakdown of why this information is not present in the provided text:

    • Focus of the Submission: The key phrase in the document is "This 510(k) proposes a new indication and labeling for the ArthroCare Topaz ArthroWands. The technology, principle of operation, and sterilization parameters of the ArthroCare Topaz ArthroWands remain the same as those Wand cleared in the predicate 510(k)s." This indicates that the core device's fundamental safety and efficacy were established in previous clearances (K011083, K052686).
    • "Substantial Equivalence" Pathway: The 510(k) pathway, particularly for modifications like this, relies on demonstrating "substantial equivalence" to a legally marketed predicate device. This often means showing that the changes (in this case, new indications) do not raise new questions of safety or effectiveness. When the underlying technology and operating principles are unchanged, extensive new performance testing may not be required beyond demonstrating continued performance for the new indications, often through literature review or limited clinical data if applicable.
    • Missing from the Documentation: The provided 510(k) summary and the FDA's clearance letter do not contain sections detailing specific performance acceptance criteria or the results of a study designed to meet them for this submission. Such details would typically be found in a separate section of the full 510(k) submission, often titled "Performance Data," "Bench Testing," or "Clinical Data," which is not part of this summary.

    Therefore, I cannot provide the requested information from the provided text.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1